Vitamin K1 5 MG Oral Tablet — RxCUI 198102
RxNorm drug concept · Semantic clinical drug
RxCUI 198102
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
19 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198102
Official nameVitamin K1 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asphytonadione 5 MG Oral Tablet
FDA products mapped12
Package NDCs mapped19
Reported Medicaid activity (SDUD)5,989 prescriptions · 29 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Phytonadione: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Phytonadione is simply vitamin K1 — the same vitamin K your body uses to make clotting proteins in the liver. Your doctor has prescribed it because your blood isn't clotting proper...
- What exactly is phytonadione, and why has my doctor prescribed it?
- Phytonadione is not instant. If you're receiving it by injection into a vein, you may start to see improvement in your clotting levels within one to two hours, and bleeding is usua...
- Yes — and this is important to understand. Phytonadione directly counteracts warfarin's blood-thinning effect, which is exactly why it's used when your INR is dangerously high. How...
🕸️ Concept Web — How Vitamin K1 5 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Vitamin K1 5 MG Oral Tablet
RxCUI 198102 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Vitamin K1
8308IN
-
Vitamin K1
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Mephyton
218324BN
-
Mephyton
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Vitamin K1 Oral Tablet
373450SCDF -
Vitamin K1 Oral Product
1161772SCDG -
Vitamin K1 Pill
1161773SCDG -
Vitamin K1 Oral Tablet [Mephyton]
368079SBDF -
Mephyton Oral Product
1184388SBDG -
Mephyton Pill
1184389SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Vitamin K1 Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Vitamin K1 5 MG
316519SCDC -
Vitamin K1 5 MG Oral Tablet [Mephyton]
207839SBD -
Vitamin K1 5 MG [Mephyton]
568572SBDC
-
Vitamin K1 5 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Vitamin K1 5 MG
SCDC · 316519 -
Vitamin K1 Oral Tablet
SCDF · 373450 -
Vitamin K1 Oral Product
SCDG · 1161772 -
Vitamin K1 Pill
SCDG · 1161773
Brand-Name Concepts
-
Vitamin K1 5 MG Oral Tablet [Mephyton]
SBD · 207839 -
Vitamin K1 5 MG [Mephyton]
SBDC · 568572 -
Vitamin K1 Oral Tablet [Mephyton]
SBDF · 368079 -
Mephyton Oral Product
SBDG · 1184388 -
Mephyton Pill
SBDG · 1184389 -
Mephyton
BN · 218324
📦 FDA Products & Package NDCs
12 products · 19 package NDCs
19 package NDCs map to RxCUI 198102 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00904-6882-10 | 20 BLISTER PACK in 1 CARTON (0904-6882-10) / 1 TABLET in 1... | Phytonadione | Major Pharmaceuticals | 2018-05-15 |
| 16714-0973-02 | 1 BOTTLE in 1 CARTON (16714-973-02) / 30 TABLET in 1 BOTTLE | Phytonadione | Northstar Rx LLC. | 2022-03-22 |
| 42291-0566-30 | 1 BOTTLE in 1 BOX (42291-566-30) / 30 TABLET in 1 BOTTLE | Phytonadione | AvKARE | 2023-09-07 |
| 50228-0333-01 | 1 BOTTLE in 1 CARTON (50228-333-01) / 100 TABLET in 1 BOTTL... | Phytonadione | ScieGen Pharmaceuticals Inc | 2023-07-28 |
| 50228-0333-30 | 1 BOTTLE in 1 CARTON (50228-333-30) / 30 TABLET in 1 BOTTLE | Phytonadione | ScieGen Pharmaceuticals Inc | 2023-07-28 |
| 60687-0381-94 | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-381-94) / 1 TABL... | Phytonadione | American Health Packaging | 2018-06-21 |
| 67046-1581-03 | 30 TABLET in 1 BLISTER PACK (67046-1581-3) | Phytonadione | Coupler LLC | 2025-09-08 |
| 69097-0999-02 | 30 TABLET in 1 BOTTLE (69097-999-02) | Phytonadione | Cipla USA., Inc. | 2023-12-01 |
| 69097-0999-07 | 100 TABLET in 1 BOTTLE (69097-999-07) | Phytonadione | Cipla USA., Inc. | 2023-12-01 |
| 69238-1051-01 | 1 BOTTLE in 1 CARTON (69238-1051-1) / 100 TABLET in 1 BOTTL... | Phytonadione | Amneal Pharmaceuticals NY LLC | 2018-05-15 |
| 69238-1051-03 | 1 BOTTLE in 1 CARTON (69238-1051-3) / 30 TABLET in 1 BOTTLE | Phytonadione | Amneal Pharmaceuticals NY LLC | 2018-05-15 |
| 70710-1014-01 | 1 BOTTLE in 1 CARTON (70710-1014-1) / 100 TABLET in 1 BOTTL... | Phytonadione | Zydus Pharmaceuticals USA Inc. | 2019-02-22 |
| 70710-1014-03 | 30 TABLET in 1 BOTTLE (70710-1014-3) | Phytonadione | Zydus Pharmaceuticals USA Inc. | 2021-11-01 |
| 70710-1014-04 | 10 BLISTER PACK in 1 CARTON (70710-1014-4) / 10 TABLET in 1... | Phytonadione | Zydus Pharmaceuticals USA Inc. | 2019-02-22 |
| 70771-1318-01 | 1 BOTTLE in 1 CARTON (70771-1318-1) / 100 TABLET in 1 BOTTL... | Phytonadione | Zydus Lifesciences Limited | 2019-02-22 |
| 70771-1318-03 | 30 TABLET in 1 BOTTLE (70771-1318-3) | Phytonadione | Zydus Lifesciences Limited | 2021-11-01 |
| 70771-1318-04 | 10 BLISTER PACK in 1 CARTON (70771-1318-4) / 10 TABLET in 1... | Phytonadione | Zydus Lifesciences Limited | 2019-02-22 |
| 72134-0008-01 | 100 TABLET in 1 BOTTLE (72134-008-01) | Phytonadione | Agnitio Inc. | 2022-02-11 |
| 76282-0740-30 | 1 BOTTLE in 1 CARTON (76282-740-30) / 30 TABLET in 1 BOTTLE | Phytonadione | Exelan Pharmaceuticals, Inc. | 2023-12-01 |
Observed labelers:
Zydus Lifesciences Limited (3) ·
Zydus Pharmaceuticals USA Inc. (3) ·
Amneal Pharmaceuticals NY LLC (2) ·
Cipla USA., Inc. (2) ·
ScieGen Pharmaceuticals Inc (2) ·
Agnitio Inc. (1)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$9.3807
Range $9.3807–$9.3807
· middle 50% $9.3807–$9.3807
· 9 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.